A detailed history of Rb Capital Management, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Rb Capital Management, LLC holds 7,020 shares of MRK stock, worth $896,594. This represents 0.26% of its overall portfolio holdings.

Number of Shares
7,020
Previous 6,554 7.11%
Holding current value
$896,594
Previous $714,000 29.69%
% of portfolio
0.26%
Previous 0.22%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$113.24 - $131.95 $52,769 - $61,488
466 Added 7.11%
7,020 $926,000
Q4 2023

Feb 05, 2024

SELL
$100.18 - $109.02 $15,728 - $17,116
-157 Reduced 2.34%
6,554 $714,000
Q3 2023

Nov 15, 2023

BUY
$102.95 - $114.33 $3,809 - $4,230
37 Added 0.55%
6,711 $690,000
Q2 2023

Dec 11, 2023

SELL
$108.61 - $118.38 $4,018 - $4,380
-37 Reduced 0.55%
6,674 $770,000
Q2 2023

Aug 07, 2023

SELL
$108.61 - $118.38 $5,213 - $5,682
-48 Reduced 0.71%
6,674 $770,000
Q1 2023

May 09, 2023

BUY
$102.94 - $114.86 $29,646 - $33,079
288 Added 4.48%
6,722 $715,000
Q4 2022

Jan 10, 2023

SELL
$87.44 - $112.11 $8,131 - $10,426
-93 Reduced 1.42%
6,434 $714,000
Q3 2022

Oct 21, 2022

BUY
$84.53 - $94.96 $3,550 - $3,988
42 Added 0.65%
6,527 $562,000
Q2 2022

Jul 14, 2022

BUY
$83.49 - $94.64 $3,924 - $4,448
47 Added 0.73%
6,485 $591,000
Q1 2022

Apr 11, 2022

BUY
$73.51 - $82.4 $147 - $164
2 Added 0.03%
6,438 $528,000
Q4 2021

Feb 14, 2022

BUY
$72.28 - $90.54 $19,804 - $24,807
274 Added 4.45%
6,436 $493,000
Q3 2021

Nov 12, 2021

BUY
$71.68 - $78.83 $2,508 - $2,759
35 Added 0.57%
6,162 $463,000
Q2 2021

Aug 06, 2021

SELL
$70.31 - $77.77 $10,124 - $11,198
-144 Reduced 2.3%
6,127 $477,000
Q1 2021

May 11, 2021

SELL
$68.86 - $81.11 $36,426 - $42,907
-529 Reduced 7.78%
6,271 $483,000
Q4 2020

Feb 04, 2021

SELL
$71.77 - $79.65 $20,597 - $22,859
-287 Reduced 4.05%
6,800 $556,000
Q3 2020

Nov 12, 2020

SELL
$73.18 - $82.95 $6,659 - $7,548
-91 Reduced 1.27%
7,087 $576,000
Q2 2020

Jul 31, 2020

BUY
$70.42 - $80.13 $29,294 - $33,334
416 Added 6.15%
7,178 $555,000
Q1 2020

May 15, 2020

BUY
$63.36 - $87.82 $1,140 - $1,580
18 Added 0.27%
6,762 $520,000
Q4 2019

Feb 11, 2020

BUY
$77.58 - $87.54 $2,560 - $2,888
33 Added 0.49%
6,744 $615,000
Q3 2019

Oct 10, 2019

BUY
$76.08 - $82.93 $34,388 - $37,484
452 Added 7.22%
6,711 $566,000
Q2 2019

Aug 07, 2019

BUY
$69.84 - $81.59 $66,767 - $78,000
956 Added 18.03%
6,259 $525,000
Q1 2019

May 08, 2019

BUY
$69.58 - $79.36 $1,878 - $2,142
27 Added 0.51%
5,303 $441,000
Q4 2018

Jan 15, 2019

BUY
$65.24 - $75.71 $1,370 - $1,589
21 Added 0.4%
5,276 $403,000
Q3 2018

Nov 13, 2018

SELL
$57.69 - $67.84 $11,480 - $13,500
-199 Reduced 3.65%
5,255 $373,000
Q2 2018

Jul 30, 2018

BUY
$50.83 - $59.72 $7,217 - $8,480
142 Added 2.67%
5,454 $331,000
Q1 2018

Apr 19, 2018

SELL
$50.96 - $59.23 $22,575 - $26,238
-443 Reduced 7.7%
5,312 $289,000
Q4 2017

Feb 05, 2018

BUY
$51.62 - $61.64 $1,496 - $1,787
29 Added 0.51%
5,755 $324,000
Q3 2017

Nov 13, 2017

BUY
$58.67 - $63.13 $335,944 - $361,482
5,726
5,726 $0

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $324B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Rb Capital Management, LLC Portfolio

Follow Rb Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rb Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rb Capital Management, LLC with notifications on news.